Introduction: The Halabi model predicts the overall survival (OS) of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with second-line therapy after docetaxel. We aimed to validate this model externally with an independent cohort, outside the setting of a clinical trial.
Methods: In a multi-institutional study, we included 66 patients treated with cabazitaxel after docetaxel for mCRPC. Patients were stratified according to the two- and three-risk groups of the Halabi nomogram. Kaplan-Meier and Cox proportional hazard analyses were performed to estimate survival and hazard ratios (HRs). The model performance was assessed using receiver operating characteristic curves, and the associated c-index (area under the curve [AUC]).
Results: The median OS in the two-risk groups was 5.06 months in the high-risk group (n=22) and 12.9 months in the low-risk group (n=44, p<0.001). High-risk patients had an HR of 9.50 (95% confidence interval (CI) 4.12-21.6, p<0.001) compared to low-risk patients. For the three-risk groups, the median OS was 6.44 months in the high-risk group (n=15), 5.75 months in the intermediate-risk group (n=11), and 13.7 months in the low-risk group (n=40, p=0.84). Compared to low-risk patients, intermediate-risk patients had an HR of 7.49 (95% CI 3.08-20.4, p<0.001), and high-risk patients had an HR of 8.48 (95% CI, 3.39-21.7, p<0.001). The AUC was 0.72 (95% CI 0.64-0.76) for the two-risk stratification. When comparing different risks, the AUCs were 0.48 (high vs intermediate), 0.66 (high vs low), and 0.65 (intermediate vs low).
Conclusions: The two-risk stratification version but not the three-risk group analysis confirmed the ability of the model to predict survival. These results support the value of the Halabi nomogram in men receiving post-docetaxel second-line chemotherapy for mCRPC.
"}],"abstractLicenseFlag":"disallow"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1410855035370980612","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Sakamoto Naotaka"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980614","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Blas Leandro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980609","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Seki Narihito"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Kyushu Central Hospital, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980615","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Shiota Masaki"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980608","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Eto Masatoshi"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980613","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Nakamura Motonobu"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980739","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Kuroiwa Kentaro"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Miyazaki Prefectural Miyazaki Hospital, Miyazaki, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980738","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Yokomizo Akira"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Harasanshin Hospital, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980736","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Hasegawa Shuji"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Kitakyushu Municipal Medical Center, Kitakyushu, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980737","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Tomoda Toshihisa"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Oita Prefectural Hospital, Oita, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980610","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Yunoki Takakazu"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, Japanese Red Cross Fukuoka Hospital, Fukuoka, Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1410855035370980611","@type":"Researcher","foaf:name":[{"@language":"en","@value":"Harano Masahiko"}],"jpcoar:affiliationName":[{"@language":"en","@value":"Department of Urology, JCHO Kyushu Hospital, Kitakyushu, Japan"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"2433328X"},{"@type":"EISSN","@value":"24333298"},{"@type":"ISSN","@value":"24333298"},{"@type":"LISSN","@value":"2433328X"}],"prism:publicationName":[{"@language":"en","@value":"JMA Journal"},{"@language":"ja","@value":"JMA Journal"}],"dc:publisher":[{"@language":"en","@value":"Japan Medical Association / The Japanese Associaiton of Medical Sciences"},{"@language":"ja","@value":"公益社団法人 日本医師会 / 日本医学会"}],"prism:publicationDate":"2022-04-15","prism:volume":"5","prism:number":"2","prism:startingPage":"224","prism:endingPage":"229"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"http://id.ndl.go.jp/digimeta/14494910"},{"@id":"https://dl.ndl.go.jp/pid/14494910"},{"@id":"https://www.jmaj.jp/download.php?id=10.31662/jmaj.2021-0198"},{"@id":"https://search.jamas.or.jp/link/ui/2023214167"}],"availableAt":"2022-04-15","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=castration-resistant%20prostate%20cancer","dc:title":"castration-resistant prostate cancer"},{"@id":"https://cir.nii.ac.jp/all?q=prognosis","dc:title":"prognosis"},{"@id":"https://cir.nii.ac.jp/all?q=cabazitaxel","dc:title":"cabazitaxel"},{"@id":"https://cir.nii.ac.jp/all?q=docetaxel","dc:title":"docetaxel"}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:2009336398"},{"@type":"NDL_SEARCH","@value":"oai:ndlsearch.ndl.go.jp:R100000039-I14494910"},{"@type":"CROSSREF","@value":"10.31662/jmaj.2021-0198"},{"@type":"OPENAIRE","@value":"doi_dedup___::5d25295425611da9263e7e5f46ac8d06"}]}